Yahoo
NasdaqGS - Nasdaq Real Time Price USD

BioCryst Pharmaceuticals, Inc. (BCRX)

8.47 +0.10 (+1.14%)
As of 12:07:48 PM EDT. Market Open.
Trade BCRX on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
940,613
874,837
450,712
331,412
270,827
Cost of Revenue
20,926
19,075
12,269
4,481
6,594
Gross Profit
919,687
855,762
438,443
326,931
264,233
Operating Expense
1,232,844
514,773
440,986
430,640
412,668
Operating Income
-313,157
340,989
-2,543
-103,709
-148,435
Net Non Operating Interest Income Expense
-65,469
-68,204
-83,770
-92,462
-93,965
Other Income Expense
-2,561
-5,394
-641
-30,058
-1,983
Pretax Income
-381,187
267,391
-86,954
-226,229
-244,383
Tax Provision
3,486
3,530
1,927
310
2,733
Net Income Common Stockholders
-384,673
263,861
-88,881
-226,539
-247,116
Diluted NI Available to Com Stockholders
-384,673
263,861
-88,881
-226,539
-247,116
Basic EPS
-1.35
1.26
-0.43
-1.18
-1.33
Diluted EPS
-1.40
1.21
-0.43
-1.18
-1.33
Basic Average Shares
229,493
209,893
206,696
192,198
185,908
Diluted Average Shares
233,995.50
218,581
206,696
192,198
185,908
Total Operating Income as Reported
-313,157
340,989
-2,543
-103,709
-148,435
Total Expenses
1,253,770
533,848
453,255
435,121
419,262
Net Income from Continuing & Discontinued Operation
-384,673
263,861
-88,881
-226,539
-247,116
Normalized Income
-376,603.60
281,170.16
-88,374.61
-202,793.18
-245,549.43
Interest Income
9,818
10,668
14,746
15,777
5,127
Interest Expense
75,287
78,872
98,516
108,239
99,092
Net Interest Income
-65,469
-68,204
-83,770
-92,462
-93,965
EBIT
-305,900
346,263
11,562
-117,990
-145,291
EBITDA
-304,197
347,652
12,808
-116,335
-143,854
Reconciled Cost of Revenue
20,926
19,075
12,269
4,481
6,594
Reconciled Depreciation
1,703
1,389
1,246
1,655
1,437
Net Income from Continuing Operation Net Minority Interest
-384,673
263,861
-88,881
-226,539
-247,116
Total Unusual Items Excluding Goodwill
-13,449
-17,484
-641
-30,058
-1,983
Total Unusual Items
-13,449
-17,484
-641
-30,058
-1,983
Normalized EBITDA
-290,748
365,136
13,449
-86,277
-141,871
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-5,379.60
-174.84
-134.61
-6,312.18
-416.43
12/31/2022 - 3/4/1994

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: